Brettman Ari David 4/A
4/A · ESSA Pharma Inc. · Filed Jan 26, 2021
Insider Transaction Report
Form 4/AAmended
ESSA Pharma Inc.EPIX
Brettman Ari David
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-12-11+16,500→ 16,500 totalExercise: $7.00Exp: 2030-12-11→ Common Shares (16,500 underlying)
Footnotes (2)
- [F1]Vesting terms have been amended such that 100% of the options vest after 12 months from the date of grant.
- [F2]The Reporting Person disclaims beneficial ownership of these securities and the inclusion of the securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or any other purpose. The Reporting Person is an employee of The Blackstone Group Inc. or one of its affiliates ("Blackstone"). Pursuant to arrangements between the Reporting Person and Blackstone, the Reporting Person is required to transfer to Blackstone any and all compensation received in connection with his directorship for any company Blackstone invests in or advises.